Frontlight ResearchEarly access
Trial site
University of California Davis Health System
- 7running trials
- 3closed trials
The trials here
What the 10 trials at this site are about, from their registry records.
- Conditions
- Spinal muscular atrophy2 trials
- Acute myeloid leukaemia1 trial
- Coronary artery disease1 trial
- Gastric and oesophageal cancer1 trial
- Sickle cell disease1 trial
- Stroke1 trial
- Thalassaemia1 trial
- Triple-negative breast cancer1 trial
- Phase
- Phase 35 trials
- Phase 21 trial
- Status
- Recruiting4 trials
- Active, not recruiting3 trials
- Completed3 trials
- Lead sponsor
- BeiGene1 trial
- Biogen1 trial
- BioNTech SE1 trial
- Daiichi Sankyo1 trial
- F2G Ltd1 trial
- and 5 more
Running trials
Recruiting
GORE® TAG® Thoracic Branch Endoprosthesis Zone 0/1 Post-Approval Study
Recruiting
Active, not recruiting
Quizartinib or Placebo Plus Chemotherapy in Newly Diagnosed Patients With FLT3-ITD Negative AML
Active, not recruiting
Active, not recruiting
Recruiting
Registry of Patients With a Diagnosis of Spinal Muscular Atrophy (SMA)
Recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Coronary artery disease1 recruiting
- Spinal muscular atrophy1 recruiting
- Triple-negative breast cancer1 recruiting
Closed trials
Completed
Completed
Completed
Site data: ClinicalTrials.govUpdated 17 Nov 2026